Logo of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)
Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) will disclose its financial results for the third quarter of 2025 before the start of trading on the Saudi Exchange (Tadawul) on Oct. 23.
The company will hold a conference call at 3:00 pm (KSA time) on the same day to discuss the financial results with investors and analysts, it said in a statement to Tadawul.
Analysts expect Jamjoom Pharma to post a net profit of SAR 115.18 million in Q3 2025, Argaam data showed.
Be the first to comment
Comments Analysis: